{
    "eid": "2-s2.0-85097224861",
    "title": "SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival",
    "cover-date": "2020-11-24",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Kitsada Wudhikarn",
        "Sanam Loghavi",
        "Abhishek A. Mangaonkar",
        "Aref Al-Kali",
        "Moritz Binder",
        "Ryan Carr",
        "Kaaren Reichard",
        "Christy Finke",
        "Matthew Howard",
        "Naseema Gangat",
        "Ayalew Tefferi",
        "Rami Komrokji",
        "Najla Ali",
        "Terra Lasho",
        "Rhett Ketterling",
        "Eric Padron",
        "Mrinal M. Patnaik"
    ],
    "citedby-count": 15,
    "ref-count": 10,
    "ref-list": [
        "SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS",
        "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia",
        "Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance",
        "Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients",
        "Revised International Prognostic Scoring System for myelodysplastic syndromes",
        "Prognostic score including gene mutations in chronic myelomonocytic leukemia",
        "ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients",
        "Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients",
        "Frequent pathway mutations of splicing machinery in myelodysplasia",
        "Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tampa",
            "@id": "60004803",
            "affilname": "Moffitt Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004803",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Kura Oncology, Incyte",
        "Mayo Clinic",
        "Henry Predolin Leukemia Foundation"
    ]
}